Ignite Creation Date:
2024-05-06 @ 10:20 AM
Last Modification Date:
2024-10-26 @ 12:28 PM
Study NCT ID:
NCT03222856
Status:
COMPLETED
Last Update Posted:
2022-06-13
First Post:
2017-07-13
Brief Title:
Ph II Study of Pembrolizumab Eribulin in Patients With HRHER2- MBC Previously Treated With Anthracyclines Taxanes
Sponsor:
MedSIR
Organization:
MedSIR
Organization Data
Organization:
MedSIR
Class:
OTHER
Study ID:
MedOPP127
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MedSIR
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None